{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:30:15Z","timestamp":1791840615090,"version":"4.3.4"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Huntington's disease (HD) is an autosomal-dominant inherited neurodegenerative disorder that is caused by expansion of a CAG-repeat tract in the huntingtin gene and characterized by motor impairment, cognitive decline, and neuropsychiatric disturbances. Neuropathological studies show that disease progression follows a characteristic pattern of brain atrophy, beginning in the basal ganglia structures. The HD Regulatory Science Consortium (HD-RSC) brings together diverse stakeholders in the HD community\u2014biopharmaceutical industry, academia, nonprofit, and patient advocacy organizations\u2014to define and address regulatory needs to accelerate HD therapeutic development. Here, the Biomarker Working Group of the HD-RSC summarizes the cross-sectional evidence indicating that regional brain volumes, as measured by volumetric magnetic resonance imaging, are reduced in HD and are correlated with disease characteristics. We also evaluate the relationship between imaging measures and clinical change, their longitudinal change characteristics, and within-individual longitudinal associations of imaging with disease progression. This analysis will be valuable in assessing pharmacodynamics in clinical trials and supporting clinical outcome assessments to evaluate treatment effects on neurodegeneration.<\/jats:p>","DOI":"10.3389\/fneur.2021.712555","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T17:05:20Z","timestamp":1638723920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Kirsi M.","family":"Kinnunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Pustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Gantman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Joules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana P.","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael I.","family":"Scahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellie","family":"Georgiou-Karistianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Huntington's Disease Regulatory Science Consortium (HD-RSC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/jnnp-2014-309768","article-title":"Short-interval observational data to inform clinical trial design in Huntington's disease","volume":"86","author":"Hobbs","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological Classification of Huntington's Disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","article-title":"Genetics and neuropathology of Huntington's disease","volume":"98","author":"Reiner","year":"2011","journal-title":"Int Rev Neurobiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuroscience.2009.01.045","article-title":"Magnetic resonance imaging of Huntington's disease: preparing for clinical trials","volume":"164","author":"Kl\u00f6ppel","year":"2009","journal-title":"Neuroscience."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S0317167100040427","article-title":"Huntington's disease: recent advances in diagnosis and management","volume":"22","author":"Furtado","year":"1995","journal-title":"Can J Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/brain\/awq047","article-title":"Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease","volume":"133","author":"Thu","year":"2010","journal-title":"Brain."},{"key":"B13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease","volume":"47","author":"de la Monte","year":"1988","journal-title":"J Neuropathol Exp Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1006\/exnr.1998.6919","article-title":"Regional specificity of brain atrophy in Huntington's disease","volume":"154","author":"Halliday","year":"1998","journal-title":"Exp Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease","volume":"82","author":"Paulsen","year":"2010","journal-title":"Brain Res Bull."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study","volume":"13","author":"Paulsen","year":"2014","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/archneur.63.6.883","article-title":"Preparing for Preventive Clinical Trials","volume":"63","author":"Paulsen","year":"2006","journal-title":"Arch Neurol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e74131","DOI":"10.1371\/journal.pone.0074131","article-title":"Multi-Modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study","volume":"8","author":"Dom\u00ednguez","year":"2013","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1192\/bjp.bp.114.156588","article-title":"Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data","volume":"208","author":"Dom\u00ednguez","year":"2016","journal-title":"Br J Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ana.410310113","article-title":"Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease","volume":"31","author":"Harris","year":"1992","journal-title":"Ann Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","article-title":"Brain structure in preclinical Huntington's disease","volume":"59","author":"Paulsen","year":"2006","journal-title":"Biol Psychiatry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/archneur.1996.00550040044013","article-title":"Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease","volume":"53","author":"Harris","year":"1996","journal-title":"Arch Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Prim."},{"key":"B25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neubiorev.2013.01.022","article-title":"Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials","volume":"37","author":"Georgiou-Karistianis","year":"2013","journal-title":"Neurosci Biobehav Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur J Neurol."},{"key":"B27","first-page":"247","article-title":"Structural imaging in premanifest and manifest Huntington disease","volume-title":"Handbook of Clinical Neurology","author":"Scahill","year":"2017"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2019.2368","article-title":"Association of CAG repeats with long-term progression in Huntington disease","volume":"76","author":"Langbehn","year":"2019","journal-title":"JAMA Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00415-010-5768-0","article-title":"Early atrophy of pallidum and accumbens nucleus in Huntington's disease","volume":"258","author":"van den Bogaard","year":"2011","journal-title":"J Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1212\/WNL.44.5.823","article-title":"Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons","volume":"44","author":"Aylward","year":"1994","journal-title":"Neurology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","article-title":"Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study","volume":"32","author":"Douaud","year":"2006","journal-title":"Neuroimage."},{"key":"B33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00702-006-0571-x","article-title":"Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease","volume":"114","author":"M\u00fchlau","year":"2007","journal-title":"J Neural Transm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington's disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1468-1331.2012.03854.x","article-title":"Evolution of brain gray matter loss in Huntington's disease: a meta-analysis","volume":"20","author":"Lambrecq","year":"2013","journal-title":"Eur J Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/acn3.558","article-title":"An image-based model of brain volume biomarker changes in Huntington's disease","volume":"5","author":"Wijeratne","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain."},{"key":"B39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JHD-130076","article-title":"Regional atrophy associated with cognitive and motor function in prodromal Huntington disease","volume":"2","author":"Aylward","year":"2013","journal-title":"J Huntingtons Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/mds.21620","article-title":"Variation of selective gray and white matter atrophy in Huntington's disease","volume":"22","author":"Jech","year":"2007","journal-title":"Mov Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1212\/WNL.0b013e3182020123","article-title":"Tapping linked to function and structure in premanifest and symptomatic Huntington disease","volume":"75","author":"Bechtel","year":"2010","journal-title":"Neurology."},{"key":"B42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hbm.21449","article-title":"Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy","volume":"34","author":"Scahill","year":"2013","journal-title":"Hum Brain Mapp."},{"key":"B43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1017\/S1355617798455061","article-title":"When does Huntington's disease begin?","volume":"4","author":"Campodonico","year":"1998","journal-title":"J Int Neuropsychol Soc."},{"key":"B44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/BF00598956","article-title":"Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study","volume":"34","author":"Starkstein","year":"1992","journal-title":"Neuroradiology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jns.2005.07.007","article-title":"Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study","volume":"239","author":"Peinemann","year":"2005","journal-title":"J Neurol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bpa.12429","article-title":"The role of the human globus pallidus in Huntington's disease","volume":"26","author":"Singh-Bains","year":"2016","journal-title":"Brain Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neulet.2007.04.049","article-title":"Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study","volume":"419","author":"Leh","year":"2007","journal-title":"Neurosci Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/archneur.1993.00540080076020","article-title":"Frontal-subcortical circuits and human behavior","volume":"50","author":"Cummings","year":"1993","journal-title":"Arch Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"B\u00e4ckman","year":"1997","journal-title":"Brain."},{"key":"B50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1212\/WNL.50.1.252","article-title":"Frontal lobe volume in patients with Huntington's disease","volume":"50","author":"Aylward","year":"1998","journal-title":"Neurology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.31887\/DCNS.2007.9.2\/rbonelli","article-title":"Frontal-subcortical circuitry and behavior","volume":"9","author":"Bonelli","year":"2007","journal-title":"Dialogues Clin Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnsys.2017.00025","article-title":"Cortico-striatal-thalamic loop circuits of the orbitofrontal cortex: promising therapeutic targets in psychiatric illness","volume":"11","author":"Fettes","year":"2017","journal-title":"Front Syst Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu Rev Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1152\/jn.00382.2005","article-title":"Different neural correlates of reward expectation and reward expectation error in the putamen and caudate nucleus during stimulus-action-reward association learning","volume":"95","author":"Haruno","year":"2006","journal-title":"J Neurophysiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pneurobio.2008.09.004","article-title":"The cognitive functions of the caudate nucleus","volume":"86","author":"Grahn","year":"2008","journal-title":"Prog Neurobiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.57.6.1025","article-title":"Striatal volume loss in HD as measured by MRI and the influence of CAG repeat","volume":"57","author":"Rosas","year":"2001","journal-title":"Neurology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.nicl.2018.05.008","article-title":"Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease","volume":"19","author":"Castro","year":"2018","journal-title":"NeuroImage Clin."},{"key":"B58","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.biopsych.2011.07.030","article-title":"Striatal volume contributes to the prediction of onset of Huntington disease in incident cases","volume":"71","author":"Aylward","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.25171","article-title":"Predicting clinical diagnosis in Huntington's disease: an imaging polymarker","volume":"83","author":"Mason","year":"2018","journal-title":"Ann Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.nicl.2016.10.009","article-title":"Early grey matter changes in structural covariance networks in Huntington's disease","volume":"12","author":"Coppen","year":"2016","journal-title":"NeuroImage Clin."},{"key":"B61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","article-title":"Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study","volume":"6","author":"Paulsen","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","article-title":"Longitudinal change in regional brain volumes in prodromal Huntington disease","volume":"82","author":"Aylward","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","article-title":"Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat","volume":"79","author":"Ruocco","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B64","doi-asserted-by":"publisher","first-page":"537977","DOI":"10.1101\/537977","article-title":"Dynamics of cortical degeneration over a decade in Huntington's disease","author":"Johnson","year":"2019","journal-title":"bioRxiv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/mds.27122","article-title":"Design optimization for clinical trials in early-stage manifest Huntington's disease","volume":"32","author":"Frost","year":"2017","journal-title":"Mov Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","article-title":"Motor, cognitive, and functional declines contribute to a single progressive factor in early HD","volume":"89","author":"Schobel","year":"2017","journal-title":"Neurology."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.712555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T16:43:43Z","timestamp":1699893823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.712555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":66,"alternative-id":["10.3389\/fneur.2021.712555"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.712555","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"article-number":"712555"}}